首页> 外文期刊>Urologic oncology >Commentary on 'Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder.' Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E, Wieland WF, Denzinger S, Otto W, Burger M, Fritsche HM. Department of Urology, Central Hospital of Bolzano, Bolzano, Italy. BJU Int 2012;110
【24h】

Commentary on 'Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder.' Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E, Wieland WF, Denzinger S, Otto W, Burger M, Fritsche HM. Department of Urology, Central Hospital of Bolzano, Bolzano, Italy. BJU Int 2012;110

机译:评论“对膀胱尿路上皮癌行根治性膀胱切除术后四种合并症指数评估围手术期死亡率的预测能力”。 Mayr R,May M,Martini T,Lodde M,Pycha A,Comploj E,Wieland WF,Denzinger S,Otto W,Burger M,Fritsche HM。意大利博尔扎诺博尔扎诺市中心医院泌尿外科。北京国际机场2012; 110

获取原文
获取原文并翻译 | 示例
       

摘要

What's known on the subject? and What does the study add? The degree of comorbidity significantly affects the course of patients with bladder cancer undergoing radical cystectomy (RC). To our knowledge this is the first study comparing four different comorbidity indices in patients undergoing RC for urothelial carcinoma to assess the best clinical predictors for 90-day perioperative mortality. We concluded that the ASA score should be the method of choice, as it showed a predictive ability superior to that of ECOG and CCI, and is much easier to generate than the ACE-27. Objective: To evaluate which of the following among the Adult Comorbidity Evaluation-27 (ACE-27), the Charlson Comorbidity Index (CCI), the Eastern Cooperative Oncology Group performance status (ECOG) and the American Society of Anesthesiologists (ASA) comorbidity scores correlate best with perioperative mortality after radical cystectomy (RC) for urothelial carcinoma (UC) of the bladder. Patients and methods: A study was carried out on 555 unselected consecutive patients without neoadjuvant chemotherapy who underwent RC for UC of the bladder from 2000 to 2010 at one of two institutions. Patients' medical records were reviewed retrospectively. We established a defined binary linear progression model based on clinical variables to predict perioperative mortality<90 days after RC (90PM). To this model we added, individually, the comorbidity indices ACE-27, CCI, ECOG, and ASA to assess their predictive capacity regarding 90PM. Results: The overall 90PM was 7.9%. Age (P = 0.01) and clinical distant metastatic tumour stage (P = 0.002) were independent predictors for 90PM in the multivariate analysis. Each of the four investigated comorbidity indices was able to significantly increase the predictive capacity of the basic model: ECOG +13.5%, (odds ratio [OR]: 1.61, P = 0.036; area under the curve [AUC] 74.7), ASA Score +28.3% (OR: 2.19, P = 0.004; AUC 76.1), Charlson Index +12.3% (OR: 1.31, P = 0.047; AUC 73.8) and ACE-27 + 29.8% (OR: 1.72, P = 0.004; AUC 76.1). Conclusions: ASA and ACE-27 show a nearly identical clinical predictive value for perioperative mortality. Both scores could be considered for clinical practice. With regard to ease of generation and availability, the ASA score can be regarded as the best instrument.
机译:关于这个主题有什么了解?该研究增加了什么?合并症的程度显着影响接受根治性膀胱切除术(RC)的膀胱癌患者的病程。据我们所知,这是第一项比较尿路上皮癌接受RC的患者的四种不同合并症指数,以评估90天围手术期死亡率的最佳临床预测指标的研究。我们得出的结论是,ASA评分应该是选择的方法,因为它显示出比ECOG和CCI更好的预测能力,并且比ACE-27更容易产生。目的:评估成人合并症评估27(ACE-27),查尔森合并症指数(CCI),东部合作肿瘤小组表现状态(ECOG)和美国麻醉医师学会(ASA)合并症评分中的以下哪个与膀胱尿路上皮癌(UC)根治性膀胱切除术(RC)后的围手术期死亡率最佳相关。患者和方法:2000年至2010年在两个机构之一对555例未经选择的未接受新辅助化疗的连续患者进行了研究,这些患者接受了RC膀胱UC。回顾性检查患者的病历。我们基于临床变量建立了定义的二进制线性进展模型,以预测RC(90PM)后<90天的围手术期死亡率。在此模型中,我们分别添加了合并症指数ACE-27,CCI,ECOG和ASA来评估90PM时的预测能力。结果:整体90PM为7.9%。年龄(P = 0.01)和临床远处转移性肿瘤分期(P = 0.002)是多因素分析中90PM的独立预测因子。四个调查的合并症指数中的每一个均能够显着提高基本模型的预测能力:ECOG +13.5%,(优势比[OR]:1.61,P = 0.036;曲线下面积[AUC] 74.7),ASA得分+ 28.3%(OR:2.19,P = 0.004; AUC 76.1),查尔森指数+ 12.3%(OR:1.31,P = 0.047; AUC 73.8)和ACE-27 + 29.8%(OR:1.72,P = 0.004; AUC 76.1)。结论:ASA和ACE-27对围手术期死亡率显示出几乎相同的临床预测价值。两个分数都可以考虑用于临床实践。关于易于生成和可用性,ASA分数可被视为最佳工具。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号